Apical membrane localization of glycogen synthase kinase 3β protein in normal colon epithelium and aberrant distribution in colorectal cancer

Cancer Letters

Volumn 275, Issue 1, 2009, Pages 158-162

  Hirakawa, Hiroshi ^a   Nakayama, Toshiyuki ^a   Shibata, Kenichiro ^a   Mihara, Yumi ^a   Taba, Mitsuru ^a   Nagayasu, Takeshi ^a   Sekine, Ichiro ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Colon; GSK 3 ; Immunohistochemistry; Subcellular localization

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; MUCIN 1; WNT PROTEIN;

APICAL MEMBRANE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELLULAR DISTRIBUTION; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BETA CATENIN; CELL MEMBRANE; CELL NUCLEUS; COLON; COLONIC NEOPLASMS; DISEASE PROGRESSION; EPITHELIUM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MODELS, BIOLOGICAL; MUCIN-1; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 58549105706     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.10.006     Document Type: Article

References (33)

1. Plyte S.E., Hughes K., Nikolakaki E., Pulverer B.J., and Woodgett J.R. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta. 1114 (1992) 147-162
2. Cohen P., and Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2 (2001) 769-776
3. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase, J. Cell Sci. 116 (2003) 1175-1186
4. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65 (2001) 391-426
5. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., and Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272 (1996) 1023-1026
6. Dimitriadis A., Vincan E., Mohammed I.M., Roczo N., Phillips W.A., and Baindur-Hudson S. Expression of Wnt genes in human colon cancers. Cancer Lett. 166 (2001) 185-191
7. Smith K., Bui T.D., Poulsom R., Kaklamanis L., Williams G., and Harris A.L. Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer. Br. J. Cancer 81 (1999) 496-502
8. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
9. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., and Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787-1790
10. van Es J.H., Barker N., and Clevers H. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr. Opin. Genet. Dev. 13 (2003) 28-33
11. Polakis P. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 17 (2007) 45-51
12. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., and Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406 (2000) 86-90
13. Schwabe R.F., and Brenner D.A. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002) G204-211
14. Shakoori A., Ougolkov A., Yu Z.W., Zhang B., Modarressi M.H., Billadeau D.D., Mai M., Takahashi Y., and Minamoto T. Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem. Biophys. Res. Commun. 334 (2005) 1365-1373
15. Farago M., Dominguez I., Landesman-Bollag E., Xu X., Rosner A., Cardiff R.D., and Seldin D.C. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res. 65 (2005) 5792-5801
16. Ougolkov A.V., Fernandez-Zapico M.E., Savoy D.N., Urrutia R.A., and Billadeau D.D. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res. 65 (2005) 2076-2081
17. Li Y., Bharti A., Chen D., Gong J., and Kufe D. Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol. Cell. Biol. 18 (1998) 7216-7224
18. Kufe D., Inghirami G., Abe M., Hayes D., Justi-Wheeler H., and Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3 (1984) 223-232
19. Pettinato G., Manivel C.J., Panico L., Sparano L., and Petrella G. Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am. J. Clin. Pathol. 121 (2004) 857-866
20. Nassar H., Pansare V., Zhang H., Che M., Sakr W., Ali-Fehmi R., Grignon D., Sarkar F., Cheng J., and Adsay V. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod. Pathol. 17 (2004) 1045-1050
21. Sakamoto K., Watanabe M., De La Cruz C., Honda H., Ise H., Mitsui K., Namiki K., Mikami Y., Moriya T., and Sasano H. Primary invasive micropapillary carcinoma of the colon. Histopathology 4 (2005) 479-484
22. Nakamura T., Mitomi H., Kanazawa H., Ohkura Y., and Watanabe M. Tumor budding as an index to identify high-risk patients with stage II colon cancer. Dis. Colon Rectum. 51 (2008) 568-572
23. Guzińska-Ustymowicz K. The role of tumour budding at the front of invasion and recurrence of rectal carcinoma. Anticancer Res. 25 (2005) 1269-1272
24. Zhang B., Ougolkov A., Yamashita K., Takahashi Y., Mai M., and Minamoto T. Beta-Catenin and ras oncogenes detect most human colorectal cancer. Clin. Cancer Res. 9 (2003) 3073-3079
25. Ougolkov A.V., Yamashita K., Mai M., and Minamoto T. Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology 122 (2002) 60-71
26. Zeng X., Tamai K., Doble B., Li S., Huang H., Habas R., Okamura H., Woodgett J., and He X. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438 (2005) 873-877
27. Cakigan K.M., and Liu Y.I. Wnt signaling: complexity at the surface. J. Cell Sci. 119 (2005) 395-402
28. Häcker U., Nybakken K., and Perrimon N. Heparan sulphate proteoglycans: the sweet side of development. Nat. Rev. Mol. Cell. Biol. 67 (2005) 530-541
29. Lin X. Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131 (2004) 6009-6021
30. Baeg G.H., Lin X., Khare N., Baumgartner S., and Perrimon N. Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless. Development 128 (2001) 87-94
31. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20 (2004) 781-810
32. Moon R.T., Kohn A.D., De Ferrari G.V., and Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5 (2004) 691-701
33. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 14 (2005) 843-850